Unicharm Co. (OTCMKTS:UNICY - Get Free Report) saw a large decline in short interest in the month of May. As of May 15th, there was short interest totalling 164,200 shares, a decline of 59.5% from the April 30th total of 405,800 shares. Currently, 0.0% of the company's shares are sold short. Based on an average daily trading volume, of 1,492,700 shares, the days-to-cover ratio is currently 0.1 days.
Unicharm Trading Up 2.2%
Shares of OTCMKTS UNICY traded up $0.09 during midday trading on Monday, hitting $4.10. The stock had a trading volume of 226,579 shares, compared to its average volume of 545,072. The company has a market capitalization of $12.02 billion, a price-to-earnings ratio of 20.50 and a beta of 0.35. Unicharm has a 1-year low of $3.48 and a 1-year high of $8.10. The company has a quick ratio of 1.79, a current ratio of 2.22 and a debt-to-equity ratio of 0.01. The company has a fifty day moving average price of $4.25 and a 200 day moving average price of $4.28.
Unicharm (OTCMKTS:UNICY - Get Free Report) last released its quarterly earnings data on Friday, May 9th. The company reported $0.05 earnings per share for the quarter. The business had revenue of $1.49 billion for the quarter, compared to analyst estimates of $1.69 billion. Unicharm had a return on equity of 10.24% and a net margin of 8.67%. On average, analysts predict that Unicharm will post 0.17 earnings per share for the current year.
About Unicharm
(
Get Free Report)
Unicharm Corporation engages in the manufacturing and sale of wellness, feminine, baby and children, kirei, and pet care products in Japan and internationally. The company's baby and child care products, including disposable diapers and wipes under the Moony, MamyPoko, Oyasumiman, and Torepanman brands; feminine care products comprise napkins, tampons, panty liners, sanitary short, panty liners, and other feminine care products under the Sofy, Center-In, and Unicharm brand names; and wellness care products include napkin-type incontinence pads, pants-type diapers, tape-type diapers, pants-type specialized urine pads, and tape-type specialized urine pads under the Lifree and Charmnap brand.
Further Reading
Before you consider Unicharm, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Unicharm wasn't on the list.
While Unicharm currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
